Author: yourhealthtech
During the Microsoft AI Tour event in Bengaluru, a select developer showcase was hosted by the company to give an overview of how developers in India are discovering opportunities in AI (artificial intelligence) to solve real-world challenges. India is a country with the transformative power of what we can do for some of the most complex challenges when it comes to education, to healthcare, to things which are happening with language barriers, they can really be simplified. And you can go to the grassroot levels to create citizen-scale solutions,” said Irina Ghose, managing director, Microsoft India.On the skilling front, Microsoft…
P&G Hygiene and Healthcare (PGHH) recorded stagnant growth in 2QFY24 (ending in June), falling short of our high single-digit growth expectations. However, PAT increased 10% YoY propelled by a soft RM basket and a favorable product price mix. GM expanded 300bp YoY to 60%. Despite flat revenue growth, ad spending rose 14% YoY (11.2% of sales vs. 9.7% YoY). GM limited the EBITDA margin expansion to 180bp YoY at 27% (best margin during the last 8-9 quarters). With a portfolio of essentials and healthcare, the company remained focused on product innovation-led customer acquisition. Penetration play will continue, but at a…
Artificial intelligence has an increasing role in the world of healthcare, and startups that bring the two worlds closer are seeing significant traction with customers, and investors. In the latest development, Ambience Healthcare — has developed what it describes as an “operating system” for healthcare organizations to help clinicians complete the substantial administrative work required of them — has raised $70 million to expand its business. Today, that business is focused in the U.S. and covers clinical work related to a wide range of ambulatory specialities (outpatient medical services) such as cardiology, oncology, pediatrics, ENT. Ambience does not disclose how many customers…
The interim budget increased coverage of Ayushman Bharat insurance and pledged greater funding for public healthcare. However, the resource bottleneck may still exist, and many more policy adjustments are required to keep India healthy. The budget proposal to integrate all ASHA workers under Ayushman Bharat will increase scheme coverage. Vaccine management through a new portal will assist reach the complete immunization aim. Policymakers understand that healthcare investments are crucial for increased economic growth. Budget funding for healthcare must increase. The interim budget announced a number of initiatives for the healthcare system, which are expected to propel it ahead in a…
India is likely to witness a surge in cancer cases, which are projected to rise from 1.46 million in 2022 to 1.57 million in 2025. The national average of cancer incidence per 100,000 individuals, stands at 100.4, which is not a very comfortable position to be in. Beyond the realms of health challenges, battling cancer in India is intricately linked with financial stability and the ongoing need for care. Cancer’s impact extends beyond health and influences financial stability.Though with advancement in medical technology, there is a significant rise in long-term survival with increasing cost related to anti-cancer treatment (with the…
Decision-making by governments involves co-opting all stakeholders to ensure that the target group benefits the most. While it is the executive’s prerogative to make policy decisions, and the legislature’s to make laws, the judiciary steps in in case of disputes. The requirement to co-opt stakeholders makes decision-making a consultative process. Various stakeholders play a crucial role in the policy-making process, including think tanks, research bodies, civil society, media, and, notably, the affected parties. The rationale behind adopting such an approach is that decision-makers cannot be experts in every subject or issue they encounter. They may also not be cognisant of…
While the fate of Steward Health Care’s nine hospitals in Massachusetts remains in doubt, lawmakers and others are discussing what — and who — is to blame for the precarious state of the medical system. Many are pointing fingers at the role of for-profit companies, like Steward, in health care. State and federal officials expect Steward to reveal its plan soon, and said they’re reviewing several potential options should Steward shutter any of its Massachusetts facilities. In a meeting last week with congressional staffers, Steward executives said the company plans to leave Massachusetts, according to U.S. Rep. Stephen Lynch, a…
Insurer Health Care Service Corp said on Wednesday it would buy Cigna (NYSE:CI)’s Medicare business that manages government-backed health insurance for people aged 65 and older for $3.3 billion in cash. The sale consists of Cigna’s Medicare lines, including Medicare Advantage, Medicare supplement and Medicare drug plans, as well as a unit called CareAllies that works with physician groups and other healthcare providers. The divestiture marks a change in Cigna’s strategy for the sector it had entered with its $3.8-billion acquisition of HealthSpring in 2011. Health Care Service holds a license to provide Blue Cross Blue Shield insurance plans in…
Sandoz, a key player in generic and biosimilar medicines, on Wednesday announced the launch of Tyruko (natalizumab) in Germany from February 1. Developed by Polpharma Biologics, Tyruko is the first and only biosimilar to treat RRMS, the company said in a statement. According to the biosimilar maker, Tyruko is indicated as a single disease-modifying therapy (DMT) in adults with highly active RRMS. This is the same indication as approved by the European Commission for reference medicine Tysabri. Early treatment with disease-modifying therapies can have a significant impact on people living with multiple sclerosis and their potential future disabilities. As the…
Lowering the Goods and Services Tax (GST) rate on health insurance products and incentivizing more and more people to buy them are some of the key expectations of the insurance sector for the upcoming interim budget in 2024. Krishnan Ramachandran, Managing Director and Chief Executive Officer, Niva Bupa Health Insurance, told ANI that 18 per cent GST rate “does not make the product more affordable.” One point I want to make which is you know all the excitement about the economy and rightfully so I think one very important ingredient is a healthy India and for a healthy India, you…